Psychiatry and Neurology, Neurology · Philadelphia, PA
NPI
1134142763
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
909 Walnut St, 2nd Floor
Philadelphia, PA, 19107
Phone (215) 955-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
558 services
Medicare patients, 2024
240
Average age 62
Drug cost, 2024
$1.3M
1,589 prescriptions
Company payments, 2025
$4,962
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael R Sperling was code 99214 (office e&m - established), 124 times for 94 patients. In total Michael R Sperling billed 558 services in 31 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-08-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 124 | 94 | $71.48 | $8,863 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 100 | 82 | $11.79 | $1,179 |
| 99214 Office E&M - Established | Office | 64 | 48 | $78.84 | $5,046 |
| 95720 Neurologic | Facility | 52 | 33 | $162.34 | $8,442 |
| 99213 Office E&M - Established | Facility | 47 | 39 | $43.68 | $2,053 |
| 95718 Neurologic | Facility | 25 | 24 | $105.58 | $2,639 |
| 99222 Hospital E&M - Initial | Facility | 21 | 21 | $94.02 | $1,974 |
| 99213 Office E&M - Established | Office | 18 | 17 | $45.99 | $828 |
By year: 2022 $58K for 602 services; 2023 $50K for 553 services; 2024 $38K for 558 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael R Sperling prescribed most often to Medicare patients was Xcopri (Cenobamate), with 245 prescriptions and refills. In total Michael R Sperling wrote 1,589 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xcopri Cenobamate | 245 | 311 | 52 | $525K |
| Lacosamide Generic | 153 | 305 | 50 | $26K |
| Briviact Brivaracetam | 143 | 166 | 27 | $243K |
| Levetiracetam Generic | 121 | 311 | 42 | $3,876 |
| Lamotrigine Generic | 115 | 281 | 35 | $2,615 |
| Fycompa Perampanel | 57 | 67 | 14 | $78K |
| Clonazepam Generic | 51 | 85 | 12 | $511 |
| Sertraline Hcl Generic | 45 | 96 | 11 | $687 |
| Topiramate Generic | 44 | 103 | 14 | $1,127 |
| Escitalopram Oxalate Generic | 43 | 113 | 13 | $800 |
| Divalproex Sodium Generic | 36 | 93 | 14 | $2,141 |
| Phenobarbital Generic | 34 | 64 | 13 | $859 |
| Clobazam Generic | 33 | 38 | Under 11 | $3,811 |
| Carbamazepine Er Carbamazepine | 29 | 43 | Under 11 | $4,381 |
| Oxcarbazepine Generic | 29 | 71 | 11 | $3,235 |
Brand drugs: 565 claims; generic drugs: 990 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael R Sperling $4,962 ($4,962 in general payments such as food, travel and fees) from 6 companies. The largest payer was SK Life Science, Inc. with $3,000.
| Company | Payments | Amount |
|---|---|---|
| SK Life Science, Inc. | 1 | $3,000 |
| Neurelis, Inc. | 2 | $1,944 |
| Pfizer Inc. PFE | 1 | $18.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.